No registrations found.
ID
Source
Brief title
Health condition
insulin resistance - insuline resistentie
diabetes - diabetes
mitochondrial function - mitochondiele functie
oxidative capacity - oxidatieve capaciteit
Sponsors and support
Maastricht University
PO Box 616, 6200 MD Maastricht
Maastricht University
PO Box 616, 6200 MD Maastricht
Intervention
Outcome measures
Primary outcome
Primary outcome parameters are skeletal muscle lipid accumulation and insulin sensitivity.
Secondary outcome
Secondary outcome measures are mitochondrial damage/oxidative capacity,
Substrate oxidation en Energy expenditure
Background summary
Skeletal muscle mitochondrial dysfunction has been linked to the development of insulin resistance and type 2 diabetes mellitus. We have suggested that muscle mitochondrial dysfunction may result from lipotoxicity: fat accumulation in skeletal muscle – as observed in insulin resistance and diabetes - could lead to impaired mitochondrial function. Interestingly, prolonged fasting (short-term ‘starvation’) also results in intramyocellular lipid accumulation and insulin resistance. Whether the mechanisms underlying are comparable, is unknown and aim of the present study.
Study objective
Prolonged fasting-induced lipid accumulation accompanied by increased levels of DAG and ceramide, will interfere with insulin signaling explaining the insulin resistant glucose uptake.
High levels off FFA might cause a decreased oxidative capacity
Study design
Insulin sensitivity is assesed after 60 hours, biopsies are taken after 60 hours in basal and insulin stimulated condition.
Additional blood samples are taken after 12,36 and 60 hours.
Intervention
12 healthy subjects wiil undergo in random order a 60h fast (calorie-free drinks only (S)) or a control diet (50-35-15% of energy as CHO, fat and protein (FED)). During the study, subjects stayed in a respiration chamber to measure energy expenditure and substrate oxidation. Insulin-sensitivity was assessed using a hyperinsulinemic-euglycemic clamp. Muscle biopsies and blood samples were taken after each intervention period in basal and insulin-stimulated conditions. Oxidative capacity is measured with an oxygraph.
Department of Human Biology
Maastricht University Medical Center
Patrick Schrauwen
Department of Human Biology
Maastricht University Medical Center
Maastricht 6200 MD
The Netherlands
+31(0)43-388 15 02
p.schrauwen@hb.unimaas.nl
Department of Human Biology
Maastricht University Medical Center
Patrick Schrauwen
Department of Human Biology
Maastricht University Medical Center
Maastricht 6200 MD
The Netherlands
+31(0)43-388 15 02
p.schrauwen@hb.unimaas.nl
Inclusion criteria
1. Male sex;
2. Age 18-35 years;
3. BMI <25 kg/m2;
4. Sedentary;
5. Stable dietary habits;
6. Healthy;
7. No (first or second-degree) family member with diagnosed type 2 diabetes.
Exclusion criteria
1. Female sex;
2. Unstable body weight (weight gain or loss > 3 kg in the past three months);
3. Participation in a regular exercise training program during the last year before the start of the study;
4. Any medical condition requiring treatment and/or medication use;
5. Abuse of drugs and/or alcohol;
6. Participation in another biomedical study within 1 month before the first screening visit.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL1925 |
NTR-old | NTR2042 |
Other | METC University Maastricht : MEC 06-3-095 |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |